Morgan Stanley
COCH icon

Morgan Stanley’s Envoy Medical COCH Stock Holding History

Morgan Stanley’s Portfolio COCH Stock Details COCH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$72K Buy
90,921
+17,021
+23% +$11.6K ﹤0.01% 6375
2026
Q1 		$49.2K Buy
73,900
+16,800
+29% +$11.5K ﹤0.01% 6428
2025
Q4 		$37.7K Buy
57,100
+600
+1% +$475 ﹤0.01% 6514
2025
Q3 		$43.8K Buy
56,500
+5,559
+11% +$7.54K ﹤0.01% 6455
2025
Q2 		$72.3K Sell
50,941
-600
-1% -$878 ﹤0.01% 6235
2025
Q1 		$67K Buy
51,541
+10,000
+24% +$14.7K ﹤0.01% 6175
2024
Q4 		$59.4K Buy
41,541
+10,000
+32% +$22.7K ﹤0.01% 6236
2024
Q3 		$103K Hold
31,541
– – ﹤0.01% 6003
2024
Q2 		$74.4K Hold
31,541
– – ﹤0.01% 6057
2024
Q1 		$124K Buy
31,541
+28,741
+1,026% +$84.1K ﹤0.01% 5908
2023
Q4 		$5.07K Buy
+2,800
New +$5.49K ﹤0.01% 6834
2021
Q3 		– Sell
-71
Closed -$1K – 7944
2021
Q2 		$1K Buy
+71
New +$690 ﹤0.01% 7596

Other funds holding COCH

NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
BL
Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
DCA
DSG Capital Advisors Edina, Minnesota $704M AUM 34.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Focus Partners Wealth
Focus Partners Wealth Boston, Massachusetts $97.6B AUM 29.43% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
ACP
Arcus Capital Partners Atlanta, Georgia $242M AUM 20.33% 1-Year Est. Return
ECM
ExodusPoint Capital Management New York $15.5B AUM 38.81% 1-Year Est. Return

Morgan Stanley's COCH Position: Q2 2026 in Review

Morgan Stanley increased its Envoy Medical (COCH) stake by 23% in Q2 2026, buying an estimated $11.6K and bringing the position to 90,921 shares worth $72K. The position accounts for ﹤0.01% of the portfolio, ranked #6375.

Morgan Stanley first reported a position in COCH in Q2 2021 and has held it in 12 quarters since. The position peaked at $124K in Q1 2024. 31 funds tracked by Wall St. Rank hold COCH as of Q2 2026.

  • Morgan Stanley held 90,921 shares of Envoy Medical worth $72K as of Q2 2026.
  • Morgan Stanley bought 17,021 Envoy Medical shares in Q2 2026, an estimated $11.6K.
  • Envoy Medical made up ﹤0.01% of Morgan Stanley's portfolio in Q2 2026, its #6375 holding.
  • Morgan Stanley first reported a position in Envoy Medical in Q2 2021 and has held it in 12 quarters since.
  • Morgan Stanley's Envoy Medical position peaked at $124K in Q1 2024.
  • 31 funds tracked by Wall St. Rank held Envoy Medical as of Q2 2026.

Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.